SCHEMBL7925807

SCHEMBL7925807

CCC(NC(=O)c1cnc2cc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)ccc2c1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MTTP P55157 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771609 0.90 SMO (0.47) MTTP
SCHEMBL7926795 0.90 MTTP (0.52) MTTP
SCHEMBL6053015 0.89 MTTP (0.52) MTTP
SCHEMBL6889715 0.88 MTTP (0.66) MTTP
SCHEMBL6052958 0.88 MTTP (0.49) MTTP
SCHEMBL6053025 0.86 MTTP (0.49) MTTP
SCHEMBL6770179 0.86 APOB (0.54) MTTP
SCHEMBL6890386 0.85 MTTP (0.65) MTTP
SCHEMBL6052880 0.85 APOB (0.55) MTTP
SCHEMBL7920131 0.84 MTTP (0.48) MTTP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1099442-A2 Methods of administering apo B-secretion/MTP inhibitors Pfizer Products Inc. (US) 2001-05-16 EP claimed
EP-1099442-A2 Methods of administering apo B-secretion/MTP inhibitors Pfizer Products Inc. (US) 2001-05-16 EP disclosed